高级搜索
髓系肉瘤的临床特征和生存分析[J]. 肿瘤防治研究, 2013, 40(06): 538-540. DOI: 10.3971/j.issn.1000-8578.2013.06.008
引用本文: 髓系肉瘤的临床特征和生存分析[J]. 肿瘤防治研究, 2013, 40(06): 538-540. DOI: 10.3971/j.issn.1000-8578.2013.06.008
Clinical Manifestation and Survival Analysis with Myeloid Sarcoma[J]. Cancer Research on Prevention and Treatment, 2013, 40(06): 538-540. DOI: 10.3971/j.issn.1000-8578.2013.06.008
Citation: Clinical Manifestation and Survival Analysis with Myeloid Sarcoma[J]. Cancer Research on Prevention and Treatment, 2013, 40(06): 538-540. DOI: 10.3971/j.issn.1000-8578.2013.06.008

髓系肉瘤的临床特征和生存分析

Clinical Manifestation and Survival Analysis with Myeloid Sarcoma

  • 摘要: 目的 探讨髓系肉瘤(myeloid sarcoma,MS)患者的临床特征、治疗方法和预后。 方法 回顾性分析17例髓系肉瘤患者的临床特征和治疗方法,应用Kaplan-Meier法行生存分析。 结果 17例髓系肉瘤的发生部位包括淋巴结、乳腺、宫颈、眼眶等。孤立性髓系肉瘤8例,白血病性髓系肉瘤9例。MS的1年和3年总生存率为(72.0±12.0)%、(45.7±14.4)%。孤立性和白血病性髓系肉瘤3年生存率分别为(85.7±13.2)%、(51.9±17.6)%。 结论 孤立性髓系肉瘤较白血病性髓系肉瘤生存有更好的趋势。髓系肉瘤的生存与髓系疾病的类型及不良预后因素也有关。

     

    Abstract: Objective To investigate the clinical manifestations,treatment and prognosis of myeloid sarcoma(MS). Methods Clinical data of 17 MS cases were retrospectively analyzed.Survival analysis was made by Kaplan-Meier method. Results The predilection sites had lymph nodes,breast,cervix and orbit.Eight cases of isolated myeloid sarcoma and 9 case leukemia myeloid sarcoma were observed.The overall survival rate at 1 year was (72.0±12.0)% and 3 years (45.7±14.4)%.The overall survival rate of 3 year in isolated myeloid sarcoma was (85.7±13.2)%,and (51.9±17.6)% in leukemia. Conclusion Prognosis in isolated myeloid sarcoma was better than that in leukemia myeloid sarcoma.Survival of myeloid sarcoma was related to types of disease and adverse prognostic factors.

     

/

返回文章
返回